Jump to content

Bengt I. Samuelsson

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 05:56, 31 October 2020 (Add: s2cid. | You can use this bot yourself. Report bugs here. | Suggested by Abductive | Category:Nobelprize template using Wikidata property P8024 | via #UCB_Category 586/953). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Bengt Samuelsson
Born
Bengt Ingemar Samuelsson

(1934-05-21) 21 May 1934 (age 90)
Halmstad, Sweden
NationalitySweden
Alma materStockholm University
Known forprostaglandins
Awards
Scientific career
FieldsBiochemistry

Bengt Ingemar Samuelsson (born 21 May 1934) is a Swedish biochemist. He shared with Sune K. Bergström and John R. Vane the 1982 Nobel Prize for Physiology or Medicine for discoveries concerning prostaglandins and related substances.[2][3]

Education and early life

He was born in Halmstad in southwest Sweden and studied at Stockholm University, where he became a professor in 1967.

Research and career

Discussing the role of prostaglandins in the body, Samuelsson explained, "It's a control system for the cells that participates in many biological functions. There are endless possibilities of manipulating this system in drug development."[citation needed]

His research interests were originally in cholesterol metabolism with importance to reaction mechanisms. Following the structural work on prostaglandins along with Sune Bergström he was interested mainly in the transformation products of arachidonic acid. This has led to the identification of endoperoxides, thromboxanes and the leukotrienes, and his group has chiefly been involved in studying the chemistry, biochemistry and biology of these compounds and their function in biological control systems. This research has implications in numerous clinical areas, especially in thrombosis, inflammation, and allergy.

This field has grown enormously since those days. Between 1981 and 1995 about three thousand papers per year were published that specifically used the expression "prostaglandins," or related terms such as "prostacyclins," "leukotrienes," and "thromboxanes," in their labels and titles.

Bengt Samuelsson has served as a director on the boards of Pharmacia AB, NicOx SA and Schering AG and is an advisor to the venture capital fund HealthCap.[citation needed]

Awards and honors

In 1975, he was awarded the Louisa Gross Horwitz Prize from Columbia University together with Sune K. Bergström. He was elected a Foreign Member of the Royal Society (ForMemRS) in 1990.[1]

References

  1. ^ a b "Professor Bengt Samuelsson ForMemRS". London: Royal Society. Archived from the original on 2015-11-08.
  2. ^ Raju, T N (1999), "The Nobel chronicles. 1982: Sune Karl Bergström (b 1916); Bengt Ingemar Samuelsson (b 1934); John Robert Vane (b 1927)", Lancet, vol. 354, no. 9193 (published 27 November 1999), p. 1914, doi:10.1016/s0140-6736(05)76884-7, PMID 10584758, S2CID 54236400
  3. ^ Swedish Medical Association's Jubilee Award
  • Bengt I. Samuelsson on Nobelprize.org Edit this at Wikidata including the Nobel Lecture From Studies of Biochemical Mechanisms to Novel Biological Mediators: Prostaglandin Endoperoxides, Thromboxanes and Leukotrienes
Non-profit organization positions
Preceded by Chairman of the Nobel Foundation
1993–2005 		Succeeded by
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bengt_I._Samuelsson&oldid=986334924"